Liver function tests and absolute lymphocyte count at day +100 are predictive factors for extensive and severe chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplant
✍ Scribed by Fernando Silva; José A. Pérez-Simón; Teresa Caballero Velazquez; Cristina Encinas; Fermín M. Sánchez-Guijo; María Díez-Campelo; Enrique Colado; Jesús Martín; Fernanda Villanueva-Gomez; Lourdes Vazquez; Consuelo del Cañizo; Dolores Caballero; Jesús San Miguel
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 705 KB
- Volume
- 85
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
✦ Synopsis
The 2009 American Society of Hematology (ASH) annual meeting introduced novel strategies for the treatment of acute leukemia. Targeted inhibitors for both acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) represent the future of these malignancies. Inclusion of targeted treatment to combination chemotherapy may translate into improved cure rates. The most clinically relevant abstracts, all of which are published in the November 2009, 114 issue of Blood, are summarized below and are identified here by their abstract numbers.